Jump to content
RemedySpot.com

Victrelis Approved in the European Union for Treatment of Chronic Hepatitis C

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 11

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Victrelis Approved in the European Union for Treatment of Chronic Hepatitis C

From the PharmaLive.com News Archive - Jul. 18, 2011

Merck announced that the European Commission (EC) has approved Victrelis

(boceprevir) for the treatment of chronic hepatitis C (CHC) genotype 1

infection, in combination with peginterferon alfa and ribavirin, in adult

patients with compensated liver disease who are previously untreated or who

have failed previous therapy.

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Victrelis Approved in the European Union for Treatment of Chronic Hepatitis C

From the PharmaLive.com News Archive - Jul. 18, 2011

Merck announced that the European Commission (EC) has approved Victrelis

(boceprevir) for the treatment of chronic hepatitis C (CHC) genotype 1

infection, in combination with peginterferon alfa and ribavirin, in adult

patients with compensated liver disease who are previously untreated or who

have failed previous therapy.

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Victrelis Approved in the European Union for Treatment of Chronic Hepatitis C

From the PharmaLive.com News Archive - Jul. 18, 2011

Merck announced that the European Commission (EC) has approved Victrelis

(boceprevir) for the treatment of chronic hepatitis C (CHC) genotype 1

infection, in combination with peginterferon alfa and ribavirin, in adult

patients with compensated liver disease who are previously untreated or who

have failed previous therapy.

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Victrelis Approved in the European Union for Treatment of Chronic Hepatitis C

From the PharmaLive.com News Archive - Jul. 18, 2011

Merck announced that the European Commission (EC) has approved Victrelis

(boceprevir) for the treatment of chronic hepatitis C (CHC) genotype 1

infection, in combination with peginterferon alfa and ribavirin, in adult

patients with compensated liver disease who are previously untreated or who

have failed previous therapy.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...